Myostatin in idiopathic inflammatory myopathies: Serum assessment and disease activity
Neuropathology and Applied Neurobiology · 2023-02 · 49 (1)
DOI: 10.1111/nan.12849 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropathology and Applied Neurobiology, online erschienen am 07.10.2022. Verfasst von Alexandrine Mahoudeau und 13 weiteren Autor:innen. Beteiligte Einrichtung: INSERM, Center of Research in Myology UMRS 974, Sorbonne Université, Paris, France. Hauptthemen laut MEDLINE: Dermatomyositis, Myositis, Myositis, Inclusion Body. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aims
In idiopathic inflammatory myopathies (IIM), disease activity is difficult to assess, and IIM may induce severe muscle damage, especially in immune‐mediated necrotising myopathies (IMNM) and inclusion body myositis (IBM). We hypothesise that myostatin, a negative regulator of muscle mass, could be a new biomarker of disease activity and/or muscle damage.
Methods
Prospective assessment of myostatin protein level in 447 IIM serum samples (dermatomyositis [DM], n = 157; IBM, n = 72; IMNM, n = 125; and antisynthetase syndrome [ASyS], n = 93) and 59 healthy donors (HD) was performed by ELISA. A gene transcript analysis was also carried out on 18 IIM muscle biopsies and six controls to analyse myostatin and myostatin pathway‐related gene expression.
Results
IIM patients had lower myostatin circulating protein levels and gene expression compared to HD (2379 [1490; 3678] pg/ml vs 4281 [3169; 5787] pg/ml; p < 0.0001 and log2FC = −1.83; p = 0.0005, respectively). Myostatin‐related gene expression varied accordingly. Based on the Physician Global Assessment, inactive IIM patients showed higher myostatin levels than active ones. This was the case for all IIM subgroups, except IMNM where low myostatin levels were maintained (2186 [1235; 3815] vs 2349 [1518; 3922] pg/ml; p = 0.4).
Conclusions
Myostatin protein and RNA levels are decreased in all IIM patients, and protein levels correlate with disease activity. Inactive ASyS and DM patients have higher myostatin levels than active patients. Myostatin could be a marker of disease activity in these subgroups. However, IMNM patients do not have significant increase in myostatin levels after disease remission. This may highlight a new pathological disease mechanism in IMNM patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- INSERM, Center of Research in Myology UMRS 974, Sorbonne Université, Paris, France.
- Department of Internal Medicine and Clinical Immunology, Sorbonne Université, Pitié-Salpêtrière Hospital, Paris, France.
- INSERM, Association Institut de Myologie, Center of Research in Myology UMRS 974, Sorbonne Université, Paris, France.
ORCID-Profile: Alexandrine Mahoudeau
Zitieren
APA
Mahoudeau, A., Anquetil, C., Tawara, N., Khademian, H., Amelin, D., Bolko, L., Silvestro, M., Cin, J. D., Tendrel, B., Tardif, V., Mariampillai, K., Butler-Browne, G., Benveniste, O., & Allenbach, Y. (2023). Myostatin in idiopathic inflammatory myopathies: Serum assessment and disease activity. Neuropathology and Applied Neurobiology, 49(1). https://doi.org/10.1111/nan.12849
Vancouver
Mahoudeau A, Anquetil C, Tawara N, Khademian H, Amelin D, Bolko L, et al. Myostatin in idiopathic inflammatory myopathies: Serum assessment and disease activity. Neuropathology and Applied Neurobiology. 2023;49(1). doi:10.1111/nan.12849
BibTeX
@article{Mahoudeau2023,
author = {Mahoudeau, Alexandrine and Anquetil, Céline and Tawara, Nozomu and Khademian, Hossein and Amelin, Damien and Bolko, Loïs and Silvestro, Marco and Cin, Julian Dal and Tendrel, Bérénice and Tardif, Virginie and Mariampillai, Kubéraka and Butler-Browne, Gillian and Benveniste, Olivier and Allenbach, Yves},
title = {Myostatin in idiopathic inflammatory myopathies: Serum assessment and disease activity},
journal = {Neuropathology and Applied Neurobiology},
year = {2023},
volume = {49},
number = {1},
doi = {10.1111/nan.12849}
}
EUVIMED